Stay updated on Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedIsrael study locations updated: Tel Litwinsky (52621) added and Qiryat Krinitzi (52621) removed. This changes the pool of active enrollment sites for the trial in Israel.SummaryDifference0.1%

- Check13 days agoChange DetectedA new trial site in Qiryat Krinitzi, Israel (52621) has been added to the study locations, and the Tel Litwinsky, Israel site (52621) has been removed. This updates the geographic footprint of the study in Israel and may affect where participants can enroll.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor patch; no study details or page content are affected.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe study record page now renders an error indicating the content is unavailable, preventing loading of the NALA study details. A large set of study documents and materials (e.g., PDFs, SAP, protocol) have been removed from the page.SummaryDifference15%

- Check55 days agoChange DetectedThe page footer now shows Revision: v3.6.4 instead of Revision: v3.6.3, indicating a small CMS/template update. This change does not modify any study details or user-facing content.SummaryDifference0.0%

- Check77 days agoChange DetectedA new revision label v3.6.3 was added and the previous label v3.6.2 was removed, updating the page's revision history to reflect a new site version.SummaryDifference0.0%

Stay in the know with updates to Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.